Company Filing History:
2 out of 2 
2 out of 2 
1 out of 8 Years Active: 1999-2016
Title: Innovations of Markus Meyer in Heart Failure Treatment
Introduction
Markus Meyer is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of heart failure. With a total of 8 patents to his name, his work has the potential to impact patient care positively.
Latest Patents
One of his latest patents focuses on the use of natriuretic peptide for treating heart failure. This invention relates to the administration of a natriuretic peptide, such as urodilatin, to patients suffering from acute decompensated heart failure. The preferred method involves intravenously administering a composition containing an effective amount of urodilatin continuously for a period ranging from 24 to 120 hours, ideally at least 48 hours. This innovative approach aims to improve the management of heart failure and enhance patient outcomes.
Career Highlights
Throughout his career, Markus Meyer has worked with various organizations, including Cardiopep Pharma GmbH. His expertise in the medical field has allowed him to develop groundbreaking solutions that address critical health issues.
Collaborations
Markus has collaborated with esteemed professionals in his field, including Wolf-Georg Forssmann and Veselin Mitrovic. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Markus Meyer stands out as an influential inventor in the medical field, particularly in the treatment of heart failure. His innovative patents and collaborations reflect his commitment to improving patient care and advancing medical science.